↓ Skip to main content

Alzheimer’s disease, dementia, and stem cell therapy

Overview of attention for article published in Stem Cell Research & Therapy, May 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#36 of 2,773)
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
23 X users
patent
1 patent
facebook
1 Facebook page
googleplus
7 Google+ users

Citations

dimensions_citation
245 Dimensions

Readers on

mendeley
522 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Alzheimer’s disease, dementia, and stem cell therapy
Published in
Stem Cell Research & Therapy, May 2017
DOI 10.1186/s13287-017-0567-5
Pubmed ID
Authors

Thomas Duncan, Michael Valenzuela

Abstract

Alzheimer's disease (AD) represents arguably the most significant social, economic, and medical crisis of our time. Characterized by progressive neurodegenerative pathology, AD is first and foremost a condition of neuronal and synaptic loss. Repopulation and regeneration of depleted neuronal circuitry by exogenous stem cells is therefore a rational therapeutic strategy. This review will focus on recent advances in stem cell therapies utilizing animal models of AD, as well as detailing the human clinical trials of stem cell therapies for AD that are currently undergoing development.

X Demographics

X Demographics

The data shown below were collected from the profiles of 23 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 522 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 522 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 97 19%
Student > Master 71 14%
Student > Ph. D. Student 49 9%
Researcher 35 7%
Student > Doctoral Student 26 5%
Other 49 9%
Unknown 195 37%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 92 18%
Medicine and Dentistry 68 13%
Neuroscience 53 10%
Pharmacology, Toxicology and Pharmaceutical Science 23 4%
Agricultural and Biological Sciences 19 4%
Other 63 12%
Unknown 204 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 47. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 November 2022.
All research outputs
#896,691
of 25,584,565 outputs
Outputs from Stem Cell Research & Therapy
#36
of 2,773 outputs
Outputs of similar age
#17,933
of 325,123 outputs
Outputs of similar age from Stem Cell Research & Therapy
#1
of 60 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,773 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 325,123 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 60 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.